ArticleOncotarget2018

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer.

Céléna Dubuc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.